Albert Bourla, the boss of the $150 billion pharmaceutical giant Pfizer, admits leaders don’t win by always being right—the ...

Albert Bourla admitted to going to extreme lengths to “save the world” and get the vaccines out faster during the COVID-19 ...

SAN FRANCISCO, Jan 12 (Reuters) - Pfizer is preparing for ‌a consumer market for obesity drugs on ‌par with the booming business it saw after it launched erectile dysfunction drug Viagra in 1998, CEO ...

Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.

Pfizer’s CEO said on Tuesday an antiviral drug to treat COVID-19 which began a Phase 1 study in March could be available by the end of this year. On CNBC’s "Squawk Box," Pfizer CEO Albert Bourla was ...

During an appearance on CBS News Sunday, Pfizer CEO Albert Bourla said that Americans would need a fourth dose of a COVID-19 vaccine to fend off future variants of the virus. Speaking with anchor ...

"We are not going back to before Louis Pasteur times,” declared Pfizer CEO Andrew Bourla on a Tuesday morning analyst call, saying the pharma giant will continue its “long-term investment” in vaccines ...

Pfizer Chairman and CEO Albert Bourla cheered reports on Tuesday that the U.S. government was pushing to expand eligibility for Covid-19 vaccines, telling CNBC the U.S. drug giant has adequate supply ...